AMGN
AMGEN Inc.

14,569
Loading...
Loading...
News
all
press releases
Is NVO's Major Restructuring Plan an Indication to Sell the Stock?
Novo Nordisk's sweeping restructuring plan cuts 9,000 jobs, targets DKK 8 billion in savings, and shifts focus to obesity and diabetes R&D.
Zacks·21h ago
News Placeholder
More News
News Placeholder
Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug
The company holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.
Stocktwits·8d ago
News Placeholder
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
Zacks·9d ago
News Placeholder
Investing in the Age of Longevity: Silver Economy Stocks in Focus
AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.
Zacks·10d ago
News Placeholder
Here's Why Amgen (AMGN) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·10d ago
News Placeholder
Does Lilly's New Obesity Pill Data Put It Back in the Weight Game?
LLY's obesity pill orforglipron hits weight-loss and A1C goals in a phase III trial, lifting shares nearly 6% and reviving investor confidence.
Zacks·15d ago
News Placeholder
AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?
Amgen's stock is up 13.5% in 2025, fueled by strong drug sales and new biosimilars, but looming competition and pricing headwinds pose challenges.
Zacks·16d ago
News Placeholder
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Zacks·17d ago
News Placeholder
J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?
Johnson & Johnson stock surges above key moving averages as strong results, raised guidance and growth prospects fuel momentum.
Zacks·17d ago
News Placeholder
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
Zacks·20d ago

Latest AMGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.